An equation for predicting the gross oxygen uptake (gross-VO2) during walking for persons with multiple sclerosis (MS) has been developed. Predictors included walking speed and total score from the 12-Item Multiple Sclerosis Walking Scale (MSWS-12).
OBJECTIVE:
This study examined the validity of this prediction equation in another sample of persons with MS.
METHODS:
Participants were 18 persons with MS with limited mobility problems (42 ± 13 years; 14 women). Participants completed the MSWS-12. Gross-VO2 was measured with open-circuit spirometry during treadmill walking at 2.0, 3.0, and 4.0 mph (0.89, 1.34, and 1.79 m·s–1).
REULTS:
Absolute percent error was small: 8.3 ± 6.1% , 8.0 ± 5.6% , and 12.2 ± 9.0% at 2.0, 3.0, and 4.0 mph, respectively. Actual gross-VO2 did not differ significantly from predicted gross-VO2 at 2.0 and 3.0 mph, but was significantly higher than predicted gross-VO2 at 4.0 mph (p < 0.001). Bland-Altman plots indicated nearly zero mean difference between actual and predicted gross-VO2 with modest 95% confidence intervals at 2.0 and 3.0 mph, but there was some underestimation at 4.0 mph.
CONCLUSIONS:
Speed and MSWS-12 score provide valid prediction of gross-VO2 during treadmill walking at slow and moderate speeds in ambulatory persons with MS. However, there is a possibility of small underestimation for walking at 4.0 mph.
AgiovlasitisS., MotlR. W., & FernhallB. (2010). Prediction of oxygen uptake during level treadmill walking in people with multiple sclerosis. Journal of Rehabilitation Medicine, 42, 650–655.
2.
AgiovlasitisS., MotlR. W., RanadiveS. M., FahsC. A., YanH., EcholsG. H., RossowL., & FernhallB. (2011). Prediction of oxygen uptake during over-ground walking in people with and without Down syndrome. European Journal of Applied Physiology, 111, 1739–1745.
3.
AgiovlasitisS., SandroffB. M., & MotlR. W.(In press). Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis. Journal of Rehabilitation Research and Development..
4.
American College of Sports Medicine (2014). ACSM’s Guidelines for Exercise Testing and Prescription. 9th ed. Baltimore: Lippincott Williams & Wilkins.
5.
BjarnadottirO. H., KonradsdottirA. D., ReynisdottirK., & OlafssonE. (2007). Multiple sclerosis and brief moderate exercise. A randomised study. Multiple Sclerosis, 13, 776–782.
6.
BlandM. J., & AltmanD. G. (1999). Measuring agreement in method comparison studies. Statistical Methods in Medical Research, 8, 135–160.
7.
DalgasU., StenagerE., & Ingemann-HansenT. (2008). Multiple sclerosis and physical exercise: Recommendations for the application of resistance-, endurance- and combined training. Multiple Sclerosis, 14,
35–53.
8.
HobartJ. C., RiaziA., LampingD. L., FitzpatrickR., & ThompsonA. J. (2003). Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology, 60, 31–36.
9.
HoholM. J., OravE. J., & WeinerH. L. (1995). Disease steps in multiple sclerosis: A simple approach to evaluate disease progression. Neurology, 45, 251–255.
10.
HoholM. J., OravE. J., & WeinerH. L. (1999). Disease steps in multiple sclerosis: A longitudinal study comparing disease steps and EDSS to evaluate disease progression. Multiple Sclerosis, 5, 349–354.
11.
HreljacA. (1993). Preferred and energetically optimal gait transition speeds in human locomotion. Medicine and Science in Sports and Exercise, 25,
1158–1162.
12.
Kent-BraunJ. A., NgA. V., CastroM., WeinerM. W., GelinasD., DudleyG. A., & MillerR. G. (1997). Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis. Journal of Applied Physiology (1985), 83, 1998–2004.
13.
LaroccaN. G. (2011). Impact of walking impairment in multiple sclerosis: Perspectives of patients and care partners. Patient, 4,
189–201.
14.
Latimer-CheungA. E., PiluttiL. A., HicksA. L., Martin GinisK. A., FenutaA. M., MacKibbonK. A., & MotlR. W. (2013). Effects of exercise training on fitness, mobility, fatigue, and health-related quality of life among adults with multiple sclerosis: A systematic review to inform guideline development. Archives of Physical Medicine and Rehabilitation,
1800–1828e1803.
15.
LearmonthY. C., DlugonskiD. D., PiluttiL. A., SandroffB. M., & MotlR. W. (2013). The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis. Multiple Sclerosis, 19, 1784–1791.
16.
LearmonthY. C., MotlR. W., SandroffB. M., PulaJ. H., & CadavidD. (2013). Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurology, 13, 37.
17.
McArdleW. D., KatchF. I., & KatchV. L. (2015). Exercise physiology: Energy, nutrition, and human performance. Baltimore: Lippincott Williams & Wilkins.
18.
McGuiganC., & HutchinsonM. (2004). Confirming the validity and responsiveness of the Multiple SclerosisWalking Scale-12 (MSWS-12). Neurology, 62,
2103–2105.
19.
MotlR. W., & FernhallB. (2012). Accurate prediction of cardiorespiratory fitness using cycle ergometry in minimally disabled persons with relapsing-remitting multiple sclerosis. Archives of Physical Medicine and Rehabilitation, 93, 490–495.
20.
MotlR. W., McAuleyE., & SnookE. M. (2005). Physical activity and multiple sclerosis: A meta-analysis. Multiple Sclerpsos, 11,
459–463.
21.
MotlR. W., & PiluttiL. A. (2012). The benefits of exercise training in multiple sclerosis. Nature Reviews Neurology, 8, 487–497.
22.
MotlR. W., SnookE. M., AgiovlasitisS., & SuhY. (2009). Calibration of accelerometer output for ambulatory adults with multiple sclerosis. Archives of Physical Medicine and Rehabilitation, 90,
1778–1784.
23.
MotlR. W., SuhY., BalantrapuS., SandroffB. M., SosnoffJ. J., PulaJ., GoldmanM. D., & FernhallB. (2012). Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosis. BMC Neurology, 12, 6.
24.
OlgiatiR., BurgunderJ. M., & MumenthalerM. (1988). Increased energy cost of walking in multiple sclerosis: Effect of spasticity, ataxia, and weakness. Archives of PhysicalMedicine and Rehabilitation, 69, 846–849.
25.
OlgiatiR., JacquetJ., & Di PramperoP. E. (1986). Energy cost of walking and exertional dyspnea in multiple sclerosis. American Review of Respiratory Disease, 134, 1005–1010.
26.
PiluttiL. A., DlugonskiD., SandroffB. M., SuhY., PulaJ. H., SosnoffJ. J., & MotlR. W. (2013). Further validation of multiple sclerosis walking scale-12 scores based on spatiotemporal gait parameters. Archives of Physical Medicine and Rehabilitation, 94, 575–578.
27.
SosnoffJ. J., SandroffB. M., & MotlR. W. (2012). Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability. Gait Posture, 36, 154–156.
28.
TrappB. D., & NaveK. A. (2008). Multiple sclerosis: An immune or neurodegenerative disorder?. Annual Reviewof Neuroscience, 31, 247–269.
29.
WhiteL. J., & DressendorferR. H. (2004). Exercise and multiple sclerosis. Sports Medicine, 34, 1077–1100.
